Clinical efficacy, safety and pharmacokinetic properties of the plasma-derived factor IX concentrate Haemonine in previously treated patients with severe haemophilia B.
about
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in ItalyThrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies.Haemophilia B: current pharmacotherapy and future directions.Current management of hemophilia B: recommendations, complications and emerging issues.Research in haemophilia B--approaching the request for high evidence levels in a rare disease.Major and Minor Classifications for Surgery in People With Hemophilia: A Literature Review.Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates.Thrombogenicity evaluation in 221 patients with haemophilia B treated with nonacog alfa.
P2860
Q34416394-292AC006-16A1-4BE7-BCE5-7951BB8A06B6Q37984127-4E20F849-CA66-4592-928F-DCCA4FFEB41FQ38040458-5E95993F-9A6A-4B00-AC37-F65CA3D9FBEBQ38238972-0044E302-E276-4582-9F62-98319F2671DDQ38286306-3AD3ED4B-840F-4486-BC00-F53419E95897Q38691560-F117BF63-F57C-4877-9B6C-8992F4961376Q45868489-972F55D7-EDFE-47FC-9E0E-49321CF24723Q45874429-F60F7DAE-D440-4CC1-BE74-5B208EF73C36
P2860
Clinical efficacy, safety and pharmacokinetic properties of the plasma-derived factor IX concentrate Haemonine in previously treated patients with severe haemophilia B.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Clinical efficacy, safety and ...... nts with severe haemophilia B.
@en
Clinical efficacy, safety and ...... nts with severe haemophilia B.
@nl
type
label
Clinical efficacy, safety and ...... nts with severe haemophilia B.
@en
Clinical efficacy, safety and ...... nts with severe haemophilia B.
@nl
prefLabel
Clinical efficacy, safety and ...... nts with severe haemophilia B.
@en
Clinical efficacy, safety and ...... nts with severe haemophilia B.
@nl
P2093
P2860
P921
P1433
P1476
Clinical efficacy, safety and ...... nts with severe haemophilia B.
@en
P2093
A B Skotnicki
A Klukowska
P2860
P304
P356
10.1111/J.1365-2516.2011.02624.X
P577
2011-08-03T00:00:00Z